The RO I know in San Diego who does SBRT is Don Fuller. He has been doing it almost as long as Dr King. He uses CyberKnife equipment (but the equipment doesn't really matter.) He also uses a 4-day treatment plan and something called "heterogeneous planning" which more closely simulates HDR brachy. I don't know if he treats high risk patients, however, and I wouldn't do it outside of a clinical trial with its own protocol.
CADogsRUs said...
The reoccurrence /biological failure of these SBRT trials for high risk seems higher than that of the ASCENDE-RT trial -- so that begs the question of whether there is any use of Brachy boost to SBRT and/or should there be?
I don't know how you would know that. The only info on SBRT treatment for high risk comes from Alan Katz, who treated fewer than 100 high risk patients. Dr King treats high risk patients as part of a clinical trial he is running. His goal is 85% bRFS - same as ASCENDE-RT - but it's too early to tell. Here's some info on SBRT for high risk:
/pcnrv.blogspot.com/2016/08/sbrt-for-high-risk-prostate-cancer.html/pcnrv.blogspot.com/2017/03/sbrt-for-high-risk-prostate-cancer.htmlThe ROs job is vitally important. The care he takes in working out the treatment plan make all the difference. That means that doses, a variety of dose constraints, and margins must be set. The process is iterative and trade-offs are made. You want an experienced RO (and physicist) who knows how to best do this.
Brachy boost therapy is the tried-and-true for high risk pc. It comes with a higher price tag in terms of expected toxicity compared to a monotherapy. You can do it with either LDR brachy or HDR brachy -- available at either UCLA (Chang) or Cedars-Sinai (Kamrava). You can arrange to have the 20 IMRT part of the treatment done locally.